The report provides a detailed analysis essential for establishing an Asenapine production plant. It encompasses all critical aspects necessary for Asenapine production, including the cost of Asenapine production, Asenapine plant cost, Asenapine production costs, and the overall Asenapine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Asenapine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Asenapine is an atypical antipsychotic medication primarily used in the pharmaceutical industry for the treatment of psychiatric disorders, notably schizophrenia and bipolar disorder. Its industrial applications are in the development and manufacture of pharmaceutical formulations aimed at managing acute manic and mixed episodes associated with bipolar I disorder, as well as preventing relapse and maintaining clinical improvement in schizophrenia patients.
The market demand for Asenapine is driven by the global increase in schizophrenia and bipolar disorder cases, with WHO estimates indicating millions affected worldwide, necessitating effective treatment options. Asenapine offers a favourable side effect profile and unique sublingual delivery, which helps ensure rapid onset and improved patient compliance, distinguishing it from other antipsychotics, which boosts its market growth.
Increased public and medical community awareness about mental illness leads to higher diagnosis rates and treatment adoption, which contributes to the demand. Ongoing research to improve antipsychotic efficacy and safety supports market expansion, alongside innovations in drug delivery systems. The sublingual formulation demands specialised production processes and handling, influencing industrial asenapine procurement timelines and specialised material needs. Obtaining and maintaining necessary certifications and regulatory licenses affects supplier and material selection for procurement.
Raw Material for Asenapine Production
According to the Asenapine production plant project report, the various raw materials for Asenapine production include trans-lactam compound- lithium aluminium hydride.
Production Process of Asenapine
The extensive Asenapine production cost report consists of the following major industrial production process:
- Production via selective reduction: The production process of Asenapine occurs through a selective reduction of the corresponding trans-lactam compound using lithium aluminium hydride in the presence of aluminium chloride at low temperatures (-20 to -25 degree Celsius) in tetrahydrofuran solvent. This step converts the lactam to the free amine base while maintaining stereochemical integrity. The reaction mixture is then carefully quenched with sodium hydroxide solution, followed by liquid-liquid extraction using toluene and water to isolate the pure asenapine base with high yield and purity.
Properties of Asenapine
Asenapine has several distinct physical and chemical properties. Its molecular formula is C17H16ClNO with a molar mass of 285.77 g/mol. It is a solid crystalline powder, with a water solubility of around 0.0312 mg/mL and a logP (partition coefficient) roughly between 3.7 and 4.3, indicating moderate lipophilicity. The pKa value is about 7.29, reflecting its acidity/basicity profile, and it exhibits high protein binding (~95%). Its structure includes four rings, and it has a topological polar surface area (TPSA) of around 12.47 Ų, which influences its bioavailability and permeability. The compound is characterised by zero rotatable bonds and no hydrogen donors, consistent with drug-like properties, and it has a bioavailability of approximately 35% via sublingual administration.